AWE
MRNA icon

Avidian Wealth Enterprises’s Moderna MRNA Stock Holding History

Avidian Wealth Enterprises’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-1,751
Closed -$445K – 550
2021
Q4 		$445K Sell
1,751
-1,099
-39% -$321K 0.03% 323
2021
Q3 		$1.1M Buy
2,850
+650
+30% +$240K 0.08% 124
2021
Q2 		$517K Buy
+2,200
New +$393K 0.04% 218

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Avidian Wealth Enterprises's MRNA Position: Q1 2022 in Review

Avidian Wealth Enterprises sold out of Moderna (MRNA) in Q1 2022, closing a stake of 1,751 shares — an estimated $445K sold.

Avidian Wealth Enterprises first reported a position in MRNA in Q2 2021 and held it in 3 quarters. The position peaked at $1.1M in Q3 2021. 1,006 funds tracked by Wall St. Rank hold MRNA as of Q1 2022.

  • Avidian Wealth Enterprises reported no remaining Moderna position as of Q1 2022 after selling out during the quarter.
  • Avidian Wealth Enterprises sold 1,751 Moderna shares in Q1 2022, an estimated $445K.
  • Avidian Wealth Enterprises first reported a position in Moderna in Q2 2021 and held it in 3 quarters.
  • Avidian Wealth Enterprises's Moderna position peaked at $1.1M in Q3 2021.
  • 1,006 funds tracked by Wall St. Rank held Moderna as of Q1 2022.

Based on Avidian Wealth Enterprises's 13F filing for Q1 2022, filed 10 May 2022.